Literature DB >> 8943349

Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons.

A Meinke1, F Barahmand-Pour, S Wöhrl, D Stoiber, T Decker.   

Abstract

Tyrosine phosphorylation and activation of the transcription factor Stat5 occur in response to stimuli like granulocyte-macrophage colony-stimulating factor, interleukin-3, or erythropoietin that stimulate both proliferation and differentiation of hematopoietic cells. It is unclear whether Stat5 is part of a proliferative response or part of the events leading to cellular differentiation. Here we report that agents promoting differentiation but not proliferation of hematopoietic cells, like phorbol ester or both types of interferons (IFNs), activate Stat5 in promonocytic U937 cells. Both IFN types caused tyrosine phosphorylation and DNA binding of predominantly one Stat5 isoform (Stat5a) despite expression of both Stat5a and Stat5b proteins. Monocytic differentiation of U937 cells led to a strong decrease in IFN-gamma-mediated activation of Stat5 but not of Stat1. Transactivation of Stat5-target genes occurred in response to IFN-gamma, which activates both Stat5 and Stat1, but not in response to granulocyte-macrophage colony-stimulating factor, which activates only Stat5. Tyrosine phosphorylation of Stat5 is not generally part of the IFN response. IFN-gamma did not cause Stat5 activation in HeLa cells, despite the expression of both Stat5 isoforms at similar levels. By contrast, IFN-alpha caused tyrosine phosphorylation and DNA binding of exclusively the b isoform of Stat5, and activated Stat5b formed a DNA binding activity previously found in HeLa cells and designated IFN-alpha activation factor 2. Taken together, our results demonstrate that ligand binding of IFN receptors leads to an isoform-specific activation of Stat5 in a restricted number of cell lineages. Moreover, they suggest that Stat5 might be part of the differentiation response of myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943349      PMCID: PMC231697          DOI: 10.1128/MCB.16.12.6937

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  Structural analysis of the human interferon gamma receptor: a small segment of the intracellular domain is specifically required for class I major histocompatibility complex antigen induction and antiviral activity.

Authors:  J R Cook; V Jung; B Schwartz; P Wang; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 2.  Interferon response pathways--a paradigm for cytokine signalling?

Authors:  M Müller; H Ibelgaufts; I M Kerr
Journal:  J Viral Hepat       Date:  1994       Impact factor: 3.728

3.  Activation of Stat 5b in erythroid progenitors correlates with the ability of ErbB to induce sustained cell proliferation.

Authors:  G Mellitzer; O Wessely; T Decker; A Meinke; M J Hayman; H Beug
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

4.  Cytokines and growth factors signal through tyrosine phosphorylation of a family of related transcription factors.

Authors:  P Rothman; B Kreider; M Azam; D Levy; U Wegenka; A Eilers; T Decker; F Horn; H Kashleva; J Ihle
Journal:  Immunity       Date:  1994-09       Impact factor: 31.745

5.  Colony-stimulating factors and interferon-gamma activate a protein related to MGF-Stat 5 to cause formation of the differentiation-induced factor in myeloid cells.

Authors:  F Barahmand-pour; A Meinke; A Eilers; F Gouilleux; B Groner; T Decker
Journal:  FEBS Lett       Date:  1995-02-20       Impact factor: 4.124

6.  The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage.

Authors:  A Eilers; D Seegert; C Schindler; M Baccarini; T Decker
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 7.  The molecular cell biology of interferon-gamma and its receptor.

Authors:  M A Farrar; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor.

Authors:  M A Farrar; J D Campbell; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.

Authors:  J X Lin; J Mietz; W S Modi; S John; W J Leonard
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

10.  Interleukin-6 signaling via four transcription factors binding palindromic enhancers of different genes.

Authors:  S Harroch; M Revel; J Chebath
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

View more
  35 in total

Review 1.  Potential role of type I interferons in the treatment of pituitary adenomas.

Authors:  Giovanni Vitale; Michele Caraglia; Peter M van Koetsveld; Paola Maroni; Monica Marra; Annamaria Colao; Steven W J Lamberts; Francesco Cavagnini; Leo J Hofland
Journal:  Rev Endocr Metab Disord       Date:  2008-07-06       Impact factor: 6.514

2.  Deconvoluting global cytokine signaling networks in natural killer cells.

Authors:  Gabriela M Wiedemann; Endi K Santosa; Simon Grassmann; Sam Sheppard; Jean-Benoît Le Luduec; Nicholas M Adams; Celeste Dang; Katharine C Hsu; Joseph C Sun; Colleen M Lau
Journal:  Nat Immunol       Date:  2021-04-15       Impact factor: 25.606

3.  STAT5: a Target of Antagonism by Neurotropic Flaviviruses.

Authors:  Matthew G Zimmerman; James R Bowen; Circe E McDonald; Ellen Young; Ralph S Baric; Bali Pulendran; Mehul S Suthar
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

4.  Stimulated plasmacytoid dendritic cells impair human T-cell development.

Authors:  Heike Schmidlin; Wendy Dontje; Fedde Groot; Suzanne J Ligthart; Arnaud D Colantonio; Monique E Oud; Esther J Schilder-Tol; Marcel Spaargaren; Hergen Spits; Christel H Uittenbogaart; Bianca Blom
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

5.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

6.  Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3.

Authors:  A Y Karpova; L V Ronco; P M Howley
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling.

Authors:  Rebeca Burdeinick-Kerr; Dhanasekaran Govindarajan; Diane E Griffin
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.

Authors:  Katharina L Kopp; Ulrik Ralfkiaer; Lise Mette R Gjerdrum; Rikke Helvad; Ida H Pedersen; Thomas Litman; Lars Jønson; Peter H Hagedorn; Thorbjørn Krejsgaard; Robert Gniadecki; Charlotte M Bonefeld; Lone Skov; Carsten Geisler; Mariusz A Wasik; Elisabeth Ralfkiaer; Niels Ødum; Anders Woetmann
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

9.  Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.

Authors:  Reinhard Dummer; Joanna Mangana
Journal:  Biologics       Date:  2009-07-13

10.  Stat1 nuclear translocation by nucleolin upon monocyte differentiation.

Authors:  Uwe Jerke; Sergey Tkachuk; Julia Kiyan; Victoria Stepanova; Angelika Kusch; Michael Hinz; Rainer Dietz; Hermann Haller; Bianca Fuhrman; Inna Dumler
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.